The Moroccan Medicines and Health Products Agency (AMMPS) has firmly denied reports circulating in some media outlets claiming a shortage of over 600 medications for chronic diseases in the country.

In an official statement, AMMPS stated that national data does not support these reported figures. The agency noted that if such extensive shortages were real, they would cause major disruptions to the healthcare system, something that has not been observed.

The agency acknowledged that occasional supply disruptions can occur, a phenomenon seen internationally. These disruptions are primarily linked to supply chain tensions, difficulties accessing raw materials, or global market fluctuations – constraints beyond any single country’s control.

AMMPS mentioned that Morocco proactively implements necessary measures to minimize impacts and ensure treatment continuity for patients.